Navigation Links
Elevation Pharmaceuticals Presents Positive Phase 2a Results in COPD Patients at the European Respiratory Society Annual Congress
Date:9/26/2011

SAN DIEGO, Sept. 26, 2011 /PRNewswire/ -- Elevation Pharmaceuticals, Inc., a biopharmaceutical company focused on the development of new aerosol therapies for patients with respiratory diseases, announced today that it presented positive results from a Phase 2a study of EP-101 in patients with moderate to severe chronic obstructive pulmonary disease (COPD), a large and growing disease characterized by significant unmet clinical needs, at the annual meeting of the European Respiratory Society (ERS). The results demonstrated a statistically significant and well-tolerated improvement in lung function over the 24-hour time period post dosing for EP-101 versus placebo. EP-101 is a proprietary inhalation solution formulation of glycopyrrolate, a long-acting muscarinic antagonist (LAMA), delivered by an optimized, Investigational eFlow® Nebulizer System (PARI Pharma GmbH).  

The randomized, double blind, placebo controlled, cross-over, dose-ranging study evaluated the dose response, efficacy, safety and tolerability of single doses of EP-101 in 42 patients with moderate to severe COPD.  Following a single administration of one of several doses or placebo, all doses achieved a rapid onset of action (five minutes), short treatment time (two minutes), and a robust magnitude of bronchodilation compared to placebo.  The bronchodilatory improvements as assessed by forced expiratory volume in one second (FEV1), a standard measure of lung function, 24 hours after dosing was dose-dependent, statistically significant (p<0.001) at all doses compared to placebo, and clinically meaningful at several doses compared to placebo.  Favorable efficacy trends were also seen in a number of other endpoints including sustained improvements in FEV1 over the entire 24-hour period, demonstrating the potential for once-daily dosing. Throughout the study period, EP-101 was well tolerated at all doses with a comparable safety profile to placebo.

"The posit
'/>"/>

SOURCE Elevation Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Inspire MD Announce the MASTER (MGUARD for Acute ST Elevation Reperfusion) Randomized Trial in TCT2010. Study Chairman Will be Dr. Gregg Stone
2. Keryx Biopharmaceuticals Announces Completion of Patient Enrollment in Zerenex™ (Ferric Citrate) Phase 3 Long-Term Study
3. Anadys Pharmaceuticals Updates Its Presentation Date at the Stifel Nicolaus Healthcare Conference
4. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
5. Auxilium Pharmaceuticals, Inc. Announces 17 Month XIAFLEX® Safety Update
6. Anadys Pharmaceuticals to Present at Two Upcoming Investor Conferences
7. Idenix Pharmaceuticals to Present at Three Upcoming Investor Conferences
8. Auxilium Pharmaceuticals to Present at the Morgan Stanley 2011 Healthcare Conference
9. Questcor Pharmaceuticals to Present at Upcoming Investor Conferences in September
10. Planet Biopharmaceuticals, Inc. Appoints Theron (Ted) Odlaug, Ph.D. as Executive Chairman
11. Syndax Pharmaceuticals Announces Issuance of EU Patent for Entinostat
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/20/2014)... 20, 2014 MediVet America ... a groundbreaking surgery at the specialized Wolvega Horse Clinic. ... digital flexor tendon was ruptured 90% and her deep ... is a death sentence for a horse. , The ... cell treatments . This revolutionary regenerative option for ...
(Date:9/19/2014)... yields to disease risks, the biological characteristics people care ... as for heightthe textbook example of a complex traitattributes ... by multiple genetic and environmental influences, making it challenging ... genes, geneticists typically mate two individuals that differ in ... mouseand then study their descendents, looking for genes that ...
(Date:9/19/2014)... to move data would consume much less power ... as chips, transistor counts rise. , Of the ... emitters, modulators, and detectors emitters are the ... optical chips is molybdenum disulfide (MoS2), which has ... atom-thick layer. Other experimental on-chip light emitters have ...
(Date:9/19/2014)... , Sept. 19, 2014  An entire month is ... inherited neuropathies – Charcot-Marie-Tooth disease (CMT) – a debilitating ... causing extreme muscle atrophy, weakness, and foot and hand ... and millions worldwide. CMT is a progressive disease, and ... legs, requiring mobility devices such as leg braces, wheelchairs ...
Breaking Biology Technology:World’s first tendon replacement using Nanofiber and activated MediVet Stem Cell Fraction 2World’s first tendon replacement using Nanofiber and activated MediVet Stem Cell Fraction 3Want to link genes to complex traits? Start with more diversity 2Toward optical chips 2Toward optical chips 3September is Charcot-Marie-Tooth (CMT) Awareness Month - Scheduled events, activities and important partnerships announced throughout the month! 2
... discovered in 2004 at The University of Manchester by Professor ... world,s most versatile materials, and is already being used in ... Researchers from the University are presenting the vast potential ... Science Exhibition which opens today (5 July 2010). ...
... 5, 2011 Cellectis bioresearch, a subsidiary of ... has received the "Most Innovative New Service 2011" ... service offering. TALENs(1) allow for customized gene modifications, ... and now affordable new tool. This prize was ...
... Generex Biotechnology Corporation (OTCBB: GNBT) ( www.generex.com ... Curt Weldon to assist in supporting the strategic ... press conference in New York City on March ... Congressman Weldon will source, evaluate, and introduce Generex ...
Cached Biology Technology:The wonders of graphene on display 2TALEN® Access by Cellectis Bioresearch Receives "Most Innovative New Service 2011" Award at Life Science Awards 2Generex Announces U.S. Congressman Curt Weldon, Co-Founder of the Congressional Diabetes Caucus, to Champion Generex Initiatives in Asia and North America 2Generex Announces U.S. Congressman Curt Weldon, Co-Founder of the Congressional Diabetes Caucus, to Champion Generex Initiatives in Asia and North America 3Generex Announces U.S. Congressman Curt Weldon, Co-Founder of the Congressional Diabetes Caucus, to Champion Generex Initiatives in Asia and North America 4
(Date:9/21/2014)... of children with autism are significantly less likely to ... than the mothers of children who are developing normally, ... Institute has found. , Low iron intake was associated ... child if the mother was 35 or older at ... suffered from metabolic conditions such as obesity hypertension or ...
(Date:9/21/2014)... MA -- In recent years, new strains of bacteria ... Each year, these superbugs, including drug-resistant forms of tuberculosis ... and kill at least 23,000. Despite the urgent need ... classes of antibiotics in the past decade. , MIT ... these superbugs. Using a gene-editing system that can disable ...
(Date:9/19/2014)... the Jimmy Durante of dinosaurs a newly ... The new dinosaur, named Rhinorex condrupus ... Brigham Young University, lived in what is now ... Late Cretaceous period. , Rhinorex, which translates roughly ... close relative of other Cretaceous hadrosaurs like Parasaurolophus ...
Breaking Biology News(10 mins):Mothers of children with autism less likely to have taken iron supplements 2Battling superbugs 2Battling superbugs 3Battling superbugs 4New hadrosaur noses into spotlight 2
... that lives in rushing streams and waterfalls in east-central China ... flowing water by communicating ultrasonically, scientists reported March 16 in ... ultrasounds are made possible by the presence of an ear ... points out an elegant and novel solution to the problem ...
... the evolution of Earth's first animals will have to ... conditions, according to a new study by Indiana University ... Proceedings of the National Academy of Sciences. , ... the last 12 years, mainly by paleontologists working in ...
... of an event before it even happens. A team at UCL ... us before we have seen what we will remember. , ... indicate that the brain can actually get into the 'right frame ... our best if the brain is active not only at the ...
Cached Biology News:Frog’s ear canal may provide insights for understanding human hearing loss 2Frog’s ear canal may provide insights for understanding human hearing loss 3Embryos tell story of Earth's earliest animals 2Embryos tell story of Earth's earliest animals 3You will remember this 2
Complete cell culture media with cytokines...
8 different frozen tissues are mounted on positively charged glass slides...
Donor feline serum and plasma...
... These versatile vacuum cups provide flexible ... curved, or irregular surfaces. ,PFG: Flat ... Bellows cup ,PCG: Multiple Bellows cup ... from 25 to 200 mm , ...
Biology Products: